Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06930599

Circumferential Pulmonary Vein Isolation Plus Transition Zone Modification in Atrial Fibrillation Patients Without Low-Voltage Areas

Comparison of Pulmonary Vein Isolation With and Without Transitional Zone Modification in Atrial Fibrillation Patients Without Low-Voltage Areas

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
162 (estimated)
Sponsor
The First Affiliated Hospital with Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study investigates two treatments for atrial fibrillation (AF) patients without low-voltage-areas (LVAs). It aims to determine whether adding transition zone modification (TZM) to the pulmonary vein isolation (PVI) improves long-term outcomes compared to PVI alone.

Conditions

Interventions

TypeNameDescription
PROCEDUREPulmonary vein isolation plus transition zone modificationFor those who are randomized to PVI+TZM arm, additional TZM should be performed after finishing PVI ablation. PVI could be performed using open-irrigated contact-force catheter.
PROCEDUREPulmonary vein isolation aloneIn periprocedural period, all antiarrhythmic drugs were discontinued for at least 5 half-lives and amiodarone for 2 months before the procedure. An electrophysiological study was performed after overnight fasting and mild sedated state with administration of intravenous midazolam and fentanyl. PVI should be performed under the CARTO or Ensite electroanatomic mapping system using an open-irrigated contact-force ablation catheter.

Timeline

Start date
2025-04-09
Primary completion
2026-10-09
Completion
2026-10-09
First posted
2025-04-16
Last updated
2025-04-16

Source: ClinicalTrials.gov record NCT06930599. Inclusion in this directory is not an endorsement.